Gene Query: MAFK

Dataset Description Geneva Score
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 74.52
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 70.63
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 46.11
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 45.95
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 42.32
Differential gene expression in Jagged1 treated human dental pulp cells. 41.94
Active translatome profiling with RiboLace in MCF7 cells 41.38
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 40.81
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 39.43
TCF7L1 knockdown in pancreatic cancer 38.29
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 38.16
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 38.16
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 38.04
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 36.05
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 33.51
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 33.32
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 33.14
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 32.4
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 32.1
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 30.81
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 30.48
Differential analysis of gene regulation at transcript resolution by RNA-Seq 30.48
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 29.65
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 29.53
Role of COP1 on MAP kinase transcriptional output in melanoma 29.46
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 29.19
SUV420H2 knockdown in PANC-1 28.89
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 28.42
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 28.09
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 27.52
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 25.7
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 24.7
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 24.68
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 24.29
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 23.85
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 23.85
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 23.7
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 23.7
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 23.55
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 23.04
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 23.0
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 22.86
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 22.65
A novel target of EZH1/2 for treatment of mantle cell lymphoma 22.54
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 22.4
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 22.1
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 22.08
TGF-β regulation of miRNA expression in pancreatic cancer 21.9
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 21.87
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 21.55
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 21.46
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 21.36
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 21.35
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 21.23
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 20.78
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 20.78
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 20.58
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 20.46
Rorc disruption in human FG pancreatic cancer cells 20.41
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 20.27
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 19.79
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 18.99
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 18.86
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 18.86
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 18.84
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 18.57
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 18.38
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 18.25
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 18.18
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 18.1
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 18.1
circRNA-sequencing 18.08
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 17.92
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 17.55
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 17.37
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 17.37
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 17.25
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 17.25
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 17.14
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 17.14
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 17.07
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 17.02
Gene expression in PANC1 cells treated with Rakicidin 17.01
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 16.79
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 16.58
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 16.57
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 16.57
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 16.52
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 16.49
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 16.37
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 16.37
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 16.34
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 16.29
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 15.94
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 15.94
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 15.9
MOF acetyl transferase regulates transcription and respiration in mitochondria 15.87
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 15.82
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 15.81
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 15.62
Transcriptome analysis of U87 cells upon LINC00152 knockdown 15.51
Transcriptome landscape of HeLa response upon triamcinolone acetonide 15.46
Tyrosine Kinase Inhibitor Cardiotoxicity 15.36
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 15.36
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 15.35
Irf9 function in immunity in mouse 15.35
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 15.29
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 15.1
Gene expression analysis of dengue-infected cells 15.1
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 15.02
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 15.02
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 15.0
Crizotinib v. DMSO in SW480 cells 14.81
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 14.66
Gene Expression Profiling of SPOP Knocked Down Cell 14.46
Effect of mitochondria deficiency on senescence-associated gene expression 14.42
Cajal bodies are linked to genome conformation [RNA-Seq] 14.33
Cajal bodies are linked to genome conformation 14.33
Regulation of poly(A) tail and translation during the somatic cell cycle 14.04
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 14.0
hTERT promotes cell adhesion and migration independent of telomerase activity 14.0
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 13.86
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 13.77
Argonaute proteins couple chromatin silencing to alternative splicing 13.67
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 13.67
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 13.65
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 13.59
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 13.59
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 13.58
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 13.56
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 13.5
Paxillin regulates genomic networks in prostate cancer [C4-2] 13.5
The age and genomic integrity of neurons after cortical stroke in humans 13.42
IL-33 activates tumor stroma to promote intestinal polyposis 13.31
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 13.29
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 13.27
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 13.24
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 13.24
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 13.24
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 13.23
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 13.12
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 13.11
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 13.11
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 13.09
Gene expression profile of human placenta from T. Cruzi infected mothers 13.08
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 12.79
mRNA-sequencing of breast cancer subtypes and normal tissue 12.79
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 12.78
RNA-seq of cells with TET1 knockout 12.72
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 12.67
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 12.64
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 12.64
Transcriptome profiling of 5 human adenocarcinoma cell lines 12.51
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 12.29
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 12.13
Gene expression analysis in response to hypoxic pathway inhibition 12.13
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 11.92
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 11.92
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 11.86
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 11.85
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 11.73
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 11.73
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 11.69
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 11.65
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 11.54
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 11.38
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 11.32
Global epigenomic reconfiguration during mammalian brain development 11.06
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 11.05
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 11.02
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 10.99
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 10.89
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 10.89
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 10.81
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 10.8
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 10.78
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 10.77
PTHrP overexpression in MCF7 cells 10.62
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 10.56
Identification of Nrf2 regulated genes by RNA sequencing 10.55
Nrf2 regulated genes in A549 cells 10.55
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 10.55
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 10.53
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 10.52
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 10.51
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 10.51
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 10.42
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 10.39
Identifying the molecular mode of action of itraconazole in colorectal cancer 10.31
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 10.3
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 10.3
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 10.27
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 10.22
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 10.17
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 10.15
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 10.01
Regulation of highly expressed hCINAP on translatome 9.92
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 9.9
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 9.9
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 9.89
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 9.79
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 9.7
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 9.68
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 9.65
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 9.65
Intrahepatic MAIT cell gene expression revealed by RNA-seq 9.62
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 9.61
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 9.55
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 9.55
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 9.5
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 9.49
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 9.48
Effect of nuclear IL-33 on gene expression 9.42
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 9.41
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 9.39
Effect of BMP inhibition or stimulation of primary human keratinocytes 9.39
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 9.25
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 9.21
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 9.2
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 9.11
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 9.1
RNA-sequencing of human tendon after injury 9.08
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 9.03
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 9.0
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 8.95
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 8.95
AR-independent prostate cancer is sustained through FGF signaling 8.93
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 8.89
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 8.88
RNA-seq analysis of BAP1-depleted uveal melanoma cells 8.87
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 8.86
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 8.86
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 8.85
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 8.83
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 8.83
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 8.73
ARS2 is a general suppressor of pervasive transcription [RNAseq] 8.68
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 8.63
RNA-seq of stable and unstable section of human atherosclerotic plaques 8.62
Total RNA sequencing of APC mutant and wt colonic organoids 8.57
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 8.56
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 8.56
RNA-seq analysis to identify the genes regulated by p53-SET interplay 8.52
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 8.49
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 8.42
BET bromodomain inhibition 8.42
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 8.38
X-Ray induced DNA-Hydroxymethylation changes 8.37
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 8.31
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 8.26
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 8.25
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 8.23
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 8.19
Capturing the Interactome of Newly Transcribed RNA (RICK) 8.13
Capturing the Interactome of Newly Transcribed RNA 8.13
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 8.02
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 7.98
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 7.98
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 7.92
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 7.91
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 7.91
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 7.91
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 7.91
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 7.89
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 7.89
Comparison of microRNA Profiling Platforms (HTS) 7.89
Comparison of microRNA Profiling Platforms 7.89
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 7.86
Characterization of parental and rociletinib-resistant derived H1975 cell lines 7.86
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 7.84
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 7.84
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 7.84
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 7.8
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 7.79
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 7.78
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 7.69
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 7.69
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 7.65
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 7.65
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 7.64
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 7.64
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 7.64
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 7.45
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 7.44
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 7.44
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 7.43
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 7.42
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 7.38
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 7.37
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 7.35
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 7.27
Identification of transcription start sites for human A549 cell line using ReCappable-seq 7.21
Energy Metabolism during Anchorage-Independence 7.2
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 7.03
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 7.03
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 7.03
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 7.01
Regulation of hypoxia-inducible factor activity by ZMYND8 6.91
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 6.91
CD73 knockdown effect in pancreatic cancer cell lines 6.78
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 6.77
CD86 regulates a pro-survival signal in myeloma cells 6.75
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 6.73
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 6.7
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 6.69
Gene Expression Profiling of WT and KDM3A Knocked out Cell 6.69
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 6.66
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 6.65
Paxillin regulates genomic networks in prostate cancer [PC3] 6.63
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 6.61
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 6.6
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 6.55
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 6.53
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 6.48
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 6.42
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 6.38
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 6.38
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 6.32
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 6.28
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 6.26
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 6.23
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 6.15
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 6.15
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 6.13
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 6.08
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 6.04
Ribosomal protein RPL26 is the principal target of UFMylation 6.02
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 6.02
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 6.02
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 5.99
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 5.99
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 5.99
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 5.97
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 5.97
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 5.97
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 5.94
Illumina Total RNA-seq in HeLa 5.92
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 5.8
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 5.74
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 5.72
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 5.61
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 5.57
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 5.31
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 5.16
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 5.13
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 5.13
Identification of Sin3B regulated genes during quiescence 5.11
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 5.09
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 5.05
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 5.04
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 4.94
Effect of FGF13 depletion on the H460 cell line 4.91
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 4.86
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 4.83
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 4.79
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 4.79
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 4.46
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 4.45
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 4.45
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  4.42
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 4.32
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 4.25
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 4.25
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 4.25
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 4.22
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 4.21
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 4.18
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 4.04
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 4.03
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 4.03
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 4.03
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 4.01
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 3.96
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 3.93
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 3.91
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 3.9
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 3.88
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 3.85
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 3.84
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 3.78
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 3.71
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 3.71
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 3.71
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 3.69
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 3.68
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 3.67
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 3.67
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 3.66
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 3.66
CDK12 mediated transcriptional regulation in U2OS cells 3.57
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 3.52
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 3.51
RNA-seq analyisis of PUM2 knockout cells 3.51
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 3.5
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 3.48
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 3.44
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 3.35
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 3.35
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 3.32
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 3.32
Glioblastoma stem cells infected by ZIKA virus 3.3
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 3.28
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 3.27
Hepatic transcriptome of pediatric hepatoblastoma. 3.24
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 3.14
Evaluating pre-clinical models for studying NASH driven HCC. 3.14
Investigate A2M treatment on human prostate cancer and mouse liver 3.02
Investigate A2M treatment on human prostate cancer xenograft in mice 3.02
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 2.95
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 2.94
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 2.94
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 2.94
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 2.86
mRNA sequencing of oropharyngeal cancer cell lines 2.86
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 2.74
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 2.74
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 2.71
Regulating Interleukin-2 activity with engineered receptor signaling clamps 2.68
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 2.67
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 2.67
Modeling Human Cancer-induced Cachexia (Human) 2.63
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 2.55
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 2.54
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 2.54
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 2.42
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 2.42
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 2.35
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 2.33
RNA-seq data from human lymphoma cell lines 2.18
ChIP-seq and RNA-seq from human lymphoma cell lines 2.18
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 2.12
RNA splicing alteration on glioblastoma and normal neural stem cells 2.12
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 2.06
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 2.03
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 2.02
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 1.95
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 1.9
Gene expression profile of CRC-derived HILEC 1.88
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 1.76
Mutational landscape of splicing genes and functional consequences across 33 cancer types 1.73
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 1.54
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 1.52
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 1.45
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 1.44
Genome wide miR-191 target profile determined by RIP and gene expression profiling 1.44
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 1.44
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 1.44
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 1.39
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 1.37
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 1.36
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 1.32
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 1.32
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 1.29
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 1.25
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 1.24
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 1.15
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 1.08
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 1.06
RNA seq_PDX2_SHP099 1.06
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 1.03
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 0.97
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 0.92
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 0.92
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 0.92
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 0.9
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.89
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.89
Enhancer activation during EGF response 0.87
H1609088 Human RNA-Sequencing 0.84
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 0.77
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 0.75
Redifferentiation of expanded human islet β cells by inhibition of ARX 0.74
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.63
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 0.56
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 0.53
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 0.53
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.46
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.46
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 0.43
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 0.43
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 0.42
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 0.4
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 0.4
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 0.39
Downregulation of LATS kinases alters p53 to promote cell migration 0.38
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 0.32
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.31
Myc activation coordinates gene transcription and protein translation responses 0.3
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.28
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.27
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.27
Oncogenic roles of ARID5B in T-ALL 0.27
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 0.23
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 0.22
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.2
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 0.2
RNA sequencing of GlyH-101-treated MCF-7 cell line 0.17
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.14
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 0.03
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation